230 related articles for article (PubMed ID: 28595943)
1. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis.
Filardo EJ
J Steroid Biochem Mol Biol; 2018 Feb; 176():38-48. PubMed ID: 28595943
[TBL] [Abstract][Full Text] [Related]
2. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
[TBL] [Abstract][Full Text] [Related]
3. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology.
Filardo EJ; Thomas P
Endocrinology; 2012 Jul; 153(7):2953-62. PubMed ID: 22495674
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.
Jacenik D; Beswick EJ; Krajewska WM; Prossnitz ER
World J Gastroenterol; 2019 Aug; 25(30):4092-4104. PubMed ID: 31435166
[TBL] [Abstract][Full Text] [Related]
6. GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments.
Tirado-Garibay AC; Falcón-Ruiz EA; Ochoa-Zarzosa A; López-Meza JE
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834441
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
Li Y; Jia Y; Bian Y; Tong H; Qu J; Wang K; Wan XP
Cell Commun Signal; 2019 Mar; 17(1):22. PubMed ID: 30836961
[TBL] [Abstract][Full Text] [Related]
8. G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.
Sharma G; Prossnitz ER
Adv Exp Med Biol; 2017; 1043():427-453. PubMed ID: 29224106
[TBL] [Abstract][Full Text] [Related]
9. G Protein-Coupled Estrogen Receptor in Cancer and Stromal Cells: Functions and Novel Therapeutic Perspectives.
Pepermans RA; Sharma G; Prossnitz ER
Cells; 2021 Mar; 10(3):. PubMed ID: 33802978
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
11. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer.
Abbas MA; Al-Kabariti AY; Sutton C
J Steroid Biochem Mol Biol; 2024 Jul; 241():106523. PubMed ID: 38636681
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
14. What have we learned about GPER function in physiology and disease from knockout mice?
Prossnitz ER; Hathaway HJ
J Steroid Biochem Mol Biol; 2015 Sep; 153():114-26. PubMed ID: 26189910
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT.
De Francesco EM; Maggiolini M; Musti AM
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29996493
[TBL] [Abstract][Full Text] [Related]
16. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
17. The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
Friese K; Kost B; Vattai A; Marmé F; Kuhn C; Mahner S; Dannecker C; Jeschke U; Heublein S
J Cancer Res Clin Oncol; 2018 Jan; 144(1):13-19. PubMed ID: 28924735
[TBL] [Abstract][Full Text] [Related]
18. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
20. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
